Breastfeeding News and Research

Latest Breastfeeding News and Research

Maternal obesity increases health risks for mothers and their babies

Women with obesity have a range of increased health risks in pregnancy, both for them and their babies, compared with those in the healthy weight category, according to a new systematic review of research by academics at the School of Nursing and Midwifery, Trinity College Dublin, the University of Gothenberg, and City University London.

4 Jun 2015

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Novartis today announced new data from two Phase II studies of Zykadia (ceritinib), as well as one Phase II study of Tafinlar® (dabrafenib) in combination with Mekinist (trametinib) in certain patients with non-small cell lung cancer.

2 Jun 2015

Helsinn's Akynzeo for CINV prevention receives EC approval

Helsinn, the Swiss Group focused on building quality cancer care, announces today that on 27th May 2015, the European Commission (EC) approved Akynzeo® (netupitant-palonosetron) for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cisplatin-based cancer chemotherapy and moderately emetogenic cancer chemotherapy in the European Union.

2 Jun 2015

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Group Health Research Institute conducts first randomized trial to tackle vaccine hesitancy

Group Health Research Institute conducted the first randomized trial to test an intervention aimed at improving hesitancy about early childhood vaccines by working directly with doctors. Vax Northwest, a Washington state public-private partnership, developed the intervention.

2 Jun 2015

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

The presentation of 35 abstracts will demonstrate the breadth and depth of the Boehringer Ingelheim and Eli Lilly and Company Diabetes alliance portfolio at the 75th American Diabetes Association's (ADA) Scientific Sessions® in Boston, June 5-9.

29 May 2015

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.

28 May 2015

Breastfeeding duration and intelligence: an interview with Dr Bernardo Lessa Horta

Our research shows a benefit of breastfeeding on performance in IQ tests that was similar to the benefit reported in previous tests among children and adolescents, suggesting that the benefits of breastfeeding are still observed in adulthood...

26 May 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

22 May 2015

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.

8 May 2015

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.

6 May 2015

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.

25 Apr 2015

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Baby-Friendly USA announced this week that Children's Memorial Hermann Hospital has received prestigious international recognition as a Baby-Friendly designated birth facility. A hospital can only be deemed "Baby-Friendly" after the completion of a rigorous onsite assessment survey and a final review of the External Review Board.

24 Apr 2015

Electronic cigarettes pose particular risks to the developing brains, organs of young people

Although heavily promoted as a safer cigarette and an aid to quit smoking, electronic cigarettes and the nicotine they deliver pose particular risks to the developing brains and organs of children. Use of electronic cigarettes by school-age children has surpassed traditional cigarette smoking, and it is critical to recognize and understand the risks related to nicotine exposure, addiction, and the poor regulation of these products, as described in the comprehensive Review article "Electronic Cigarettes: Vulnerability of Youth," published in Pediatric Allergy, Immunology, and Pulmonology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

22 Apr 2015

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS).

21 Apr 2015

New study finds that breastfeeding may help reduce smoking

While a large number of women quit or reduce smoking upon pregnancy recognition, many resume smoking postpartum. Previous research has estimated that approximately 70% of women who quit smoking during pregnancy relapse within the first year after childbirth, and of those who relapse, 67% resume smoking by three months, and up to 90% by six months.

17 Apr 2015

Study focuses on how women experience sex after childbirth

New mothers in the Philippines spend more time in the bedroom with their partner in the first few weeks after giving birth than they did before they became pregnant.

10 Apr 2015

Breastfeeding not a cure-all front-line strategy to prevent obesity, research shows

Biologic research does not support breastfeeding as a cure-all front-line strategy to prevent obesity. Yes, while breastfeeding is the optimal first food for a baby, it's not as simple to say that it will protect all children from becoming obese.

10 Apr 2015

Breastfeeding is not a frontline strategy to prevent obesity, say researchers

A new study supports human milk as the optimal first food for babies, but the study raises questions about whether breast milk protects children from becoming obese.

7 Apr 2015

Breast milk purchased online has significant amounts of cow's milk added, study finds

A study published today on the safety of human breast milk bought over the Internet found that 10 percent of samples contained added cow's milk. The discovery that purchased samples of human milk may be purposely "topped off" with cow's milk or infant formula confirms a danger for the large number of babies receiving the purchased milk due to medical conditions.

6 Apr 2015

Breastfeeding News and Research

Latest Breastfeeding News and Research

Maternal obesity increases health risks for mothers and their babies

ASCO 2015: Novartis presents data on Zykadia and Tafinlar studies for non-small cell lung cancer

Helsinn's Akynzeo for CINV prevention receives EC approval

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Group Health Research Institute conducts first randomized trial to tackle vaccine hesitancy

Lilly Diabetes Alliance, Boehringer Ingelheim to present study results at ADA’s Scientific Sessions

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Breastfeeding duration and intelligence: an interview with Dr Bernardo Lessa Horta

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

ViiV Healthcare initiates Phase III trial to evaluate dolutegravir and rilpivirine in HIV patients

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Electronic cigarettes pose particular risks to the developing brains, organs of young people

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

New study finds that breastfeeding may help reduce smoking

Study focuses on how women experience sex after childbirth

Breastfeeding not a cure-all front-line strategy to prevent obesity, research shows

Breastfeeding is not a frontline strategy to prevent obesity, say researchers

Breast milk purchased online has significant amounts of cow's milk added, study finds

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Breastfeeding News and Research

Latest Breastfeeding News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in